OMVOH

Google image searchProduct monograph

Active ingredient

mirikizumab, 100 MG/ML

DIN: 02539853

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: PREFILLED SYRINGE

Schedule: Prescription / Schedule D

Company: ELI LILLY CANADA INC

Date: 05-DEC-2023

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AC — Interleukin inhibitors (ATC, ATC/DDD)
• L04AC24 — MIRIKIZUMAB (ATC/DDD)

Pharmaceutical standard: MFR

External Links for Omvoh

Search on Google

• Omvoh side effects
• Omvoh dosage
• mirikizumab side effects
• mirikizumab dosage

Eli Lilly Canada Inc

Go to Eli Lilly website to see drug product details. Sometimes you can find omvoh photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.